Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cancer
3.2.1.2 High cancer detection rate coupled with growing demand for effective cancer tools
3.2.1.3 Advancements in data analytics and artificial intelligence (AI) utilized in cancer screening
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of multi-cancer screening test
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Gene panel, LDT, & others
5.3 Liquid biopsy
Chapter 6 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospitals
6.3 Diagnostic laboratories
6.4 Other end-users
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 AnPac Bio-Medical Science Co., Ltd.
8.2 Burning Rock Biotech Limited
8.3 EarlyDiagnostics
8.4 Elypta AB
8.5 EXACT SCIENCES CORPORATION
8.6 Freenome Holdings, Inc.
8.7 Genecast Biotechnology Co., Ltd.
8.8 Guangzhou AnchorDx Medical Co., Ltd.
8.9 GUARDANT HEALTH, INC.
8.10 Illumina, Inc. (GRAIL, Inc.)
8.11 Micronoma, Inc.
8.12 Oncocyte Corporation
8.13 Roche Holdings, Inc (FOUNDATION MEDICINE, INC.)
8.14 SeekIn Inc.
8.15 Singlera Genomics Inc
